FIELD: pharmacology.
SUBSTANCE: invention relates to a compound of the formula (I), wherein n is 1 or 2; each X is independently N or CR1; each Z is independently N or C; each Y is independently N or CR3; provided that contains 2 or 4 nitrogen atoms in the ring; R1 is hydrogen or C1-C6 alkyl; each R3 is independently (i) hydrogen, halogen, C1-C6 alkyl; or (ii) two adjacent R3 together with the carbon atoms to which they are attached form a 5-10 membered heteroaryl ring containing one N atom; B is , , or ; (i) R4 and R5 together with the atoms to which they are attached, form a monocyclic 6-10 membered aryl ring, a monocyclic 5-10 membered heteroaryl ring containing one N atom substituted by C1-C6 alkyl, C3-C7 cycloalkyl, halogen, halogen C1-C6 alkoxy C1-C6 alkyl; or a bicyclic 5-10 membered heteroaryl ring containing one N atom substituted by halogen or a bicyclic 5-10 membered heteroaryl ring containing 3 heteroatoms selected from N and O; or (ii) R4 and R5 each independently represents hydrogen; AT1 is NR8; AT2 is a CR9; R8 is C1-C6 alkyl; and R9 is hydrogen, halogen, C1-C6 alkyl. The invention also relates to a pharmaceutical composition and to a method for treatment, prevention or control of a CNS disorder or metabolic disorder.
EFFECT: new compounds of the formula are obtained that can be used in treatment of a CNS disorder or metabolic disorder.
33 cl
Title | Year | Author | Number |
---|---|---|---|
3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND VARIANTS OF THEIR USE | 2018 |
|
RU2795850C2 |
COMPOSITIONS, SYNTHESIS AND METHODS OF APPLYING ARYLPIPERAZINE DERIVATIVES | 2010 |
|
RU2506262C2 |
COMPOSITIONS SUITABLE FOR TREATING DISORDERS ASSOCIATED WITH KIT | 2014 |
|
RU2706235C2 |
NEUROACTIVE STEROIDS, COMPOSITIONS AND USE THEREOF | 2014 |
|
RU2696585C2 |
INTEGRATED STRESS PATHWAY PRODRUG MODULATORS | 2019 |
|
RU2824500C2 |
PHOSPHORUS(N)AMIDATEACETAL AND PHOSPH(OH)ATACETAL COMPOUNDS | 2019 |
|
RU2796403C2 |
NEUROACTIVE STEROIDS SUBSTITUTED AT POSITION 10 WITH A CYCLIC GROUP FOR USE IN THE TREATMENT OF CNS DISORDERS | 2019 |
|
RU2796006C2 |
PYRROLO-PYRROLE COMPOSITIONS AS ACTIVATORS OF PYRUVATE KINASE (PKR) | 2018 |
|
RU2736217C2 |
NEUROACTIVE STEROIDS, COMPOSITIONS AND THEIR USE | 2012 |
|
RU2808165C2 |
MMPL3 INHIBITORS, COMPOSITIONS BASED ON THEM AND WAYS OF THEIR APPLICATION | 2019 |
|
RU2795229C2 |
Authors
Dates
2018-02-13—Published
2013-06-19—Filed